{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Fulgent Genetics, Inc."},"Symbol":{"label":"Symbol","value":"FLGT"},"Address":{"label":"Address","value":"4978 SANTA ANITA AVENUE,SUITE 205, TEMPLE CITY, California, 91780, United States"},"Phone":{"label":"Phone","value":"+1 626 350-0537"},"Industry":{"label":"Industry","value":"Medical Specialities"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign."},"CompanyUrl":{"label":"Company Url","value":"https://www.fulgentgenetics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"David Yu","title":"VP-IT Infrastructure"},{"name":"Elias Nyankojo","title":"Chief Information Security Officer"},{"name":"Han Lin Gao","title":"Chief Scientific Officer & Laboratory Director"},{"name":"James Xie","title":"President & Chief Operating Officer"},{"name":"Lawrence M. Weiss","title":"Chief Medical Officer"},{"name":"Ming Hsieh","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}